Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Obstetrics/Gynecology

RSS  

Articles

  • CTUpdates: Make plans now to attend fall conference

    Register now for the annual Contraceptive Technology: Quest for Excellence conference, scheduled for Oct. 27-29, 2005, in Atlanta.
  • New compounds eyed for male contraception

    The push is on to develop an effective male contraceptive, with almost $8 million from the National Institutes of Health (NIH) going to researchers at the University of Kansas in Lawrence and the University of Kansas Medical Center in Kansas City toward identifying potential chemical compounds for such use.
  • Teens & dysmenorrhea: Look to low-dose OCs

    The 15-year-old young woman in your exam room tells you that she has crampy pelvic pain that begins shortly before or at the onset of her menstrual period that lasts one to three days. She says she usually misses a day of school each month due to the pain. What is your next move?
  • Research eyes new sterilization option

    Investigators now are looking at a transcervical sterilization option that, if proven safe and effective, will give women another alternative for permanent contraception.
  • NuvaRing not affected by heavier body weight

    The next patient in your exam room is in her mid-20s. While she is in generally good health, you note she weighs in at 210 pounds. What contraceptive methods do you offer her?
  • Full September 2005 Issue in PDF

  • Washington Watch: Pharmacists’ refusals prompt legislation

    Legislators across the nation are grappling with the contentious issue of whether pharmacists have the right to refuse to fill birth control prescriptions on moral or religious grounds and in turn the obligation of pharmacies to meet the needs of consumers seeking to avoid unintended pregnancies if and when pharmacists refuse.
  • Extended use of ring, patch now under review

    With more women using oral contraceptives (OCs) in extended regimens, scientists are now focusing research on similar applications for the contraceptive vaginal ring (NuvaRing, Organon, West Orange, NJ) and the transdermal contraceptive (Ortho Evra, Ortho-McNeil Pharmaceutical, Raritan, NJ). Results from a randomized trial involving extended use of the patch have just been published, while data from a randomized study comparing extended ring regimens was presented at the May 2005 annual meeting of the American College of Obstetricians and Gynecologists.
  • Oral contraceptives: Look for more options to emerge from pipeline

    Check the last 10 contraceptive counseling sessions you conducted in your exam room. While some of your patients may have chosen new forms of birth control, chances are that most of them picked the Pill.
  • New IUDs may expand contraceptive choices

    Where does intrauterine contraception fit in the array of family planning choices you offer your patients? If you never or rarely perform intrauterine device (IUD) insertions, new devices now under development may lead you to give the method a second look.